MELK and breast cancer: In vitro function experiments demonstrated that MELK knockdown or miR-145-3p mimics partially rescued the stimulative effects of PCDHB17P overexpression on breast cancer cells migration, invasion, and angiogenesis (Figures 7C–F, Supplementary Figures 5A, B).